DA
Dr. Alan Cherrington
Scientific Founder (Distinguished Diabetes Researcher, Vanderbilt University)
Abvance TherapeuticsTherapeutic Areas
Abvance Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ABV101 | Diabetes Management (Hypoglycemia Prevention) | Pre-clinical |